SCHEMBL1374548

SCHEMBL1374548

COc1cccc(N)c1CO

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
ADRA2B P18089 1/20 0.56
PTGS1 P23219 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
KDM4E B2RXH2 3/20 0.43
LMNA P02545 2/20 0.43
MAPT P10636 2/20 0.43
HPGD P15428 2/20 0.43
TP53 P04637 2/20 0.43
CYP3A4 P08684 1/20 0.43
ALOX15 P16050 1/20 0.43
ALOX12 P18054 1/20 0.43
MAPK1 P28482 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CA1 P00915 3/20 0.42
CA2 P00918 3/20 0.42
CA12 O43570 2/20 0.42
CA7 P43166 2/20 0.42
CA9 Q16790 2/20 0.42
CA14 Q9ULX7 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30873744 1.00 ALDH1A1 (0.56) ALDH1A1ADRA2BPTGS1TDP1KDM4E
SCHEMBL505777 0.87 CA1 (0.50) ALDH1A1KDM4ELMNAMAPTHPGD
SCHEMBL9646614 0.86 ALDH1A1 (0.50) ALDH1A1ADRA2BPTGS1TDP1KDM4E
SCHEMBL28281191 0.85 ALDH1A1 (0.58) ALDH1A1ADRA2BPTGS1TDP1KDM4E
SCHEMBL1161645 0.83 ALDH1A1 (0.56) ALDH1A1ADRA2BPTGS1TDP1KDM4E
SCHEMBL4763029 0.83 ALDH1A1 (0.56) ALDH1A1ADRA2BPTGS1TDP1KDM4E
SCHEMBL996608 0.83 ALDH1A1 (0.56) ALDH1A1ADRA2BPTGS1TDP1KDM4E
SCHEMBL28319093 0.82 ALDH1A1 (0.54) ALDH1A1ADRA2BPTGS1TDP1KDM4E
SCHEMBL18185043 0.82 ALDH1A1 (0.54) ALDH1A1ADRA2BPTGS1TDP1KDM4E
Alcohol SCHEMBL28228430 0.81 ALDH1A1 (0.48) ALDH1A1ADRA2BPTGS1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250179052-A1 PYRIMIDINYL-OXY-QUINOLINE BASED HERBICIDAL COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2025-06-05 US disclosed
EP-4486735-A1 PYRIMIDINYL-OXY-QUINOLINE BASED HERBICIDAL COMPOUNDS Syngenta Crop Protection AG (CH) 2025-01-08 EP disclosed
CN-118786122-A Herbicidal compounds based on pyrimidinyl-oxy-quinolines 先正达农作物保护股份公司 2024-10-15 CN disclosed
CN-115850200-B Polymerizable 3, 1-benzoxazine substituted phenol monomer, preparation method, cured product and application 西安交通大学 2024-05-14 CN disclosed
CN-117551057-A Benzo ring derivative and preparation method and application thereof 浙江海正药业股份有限公司 2024-02-13 CN disclosed
WO-2023165874-A1 PYRIMIDINYL-OXY-QUINOLINE BASED HERBICIDAL COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2023-09-07 WO disclosed
EP-3421454-B9 PIPERIDINE DERIVATIVE OTSUKA PHARMA CO LTD (JP) 2023-08-09 EP disclosed
EP-3421454-B1 PIPERIDINE DERIVATIVE OTSUKA PHARMA CO LTD (JP) 2023-04-05 EP disclosed
CN-115850200-A Polymerizable 3, 1-benzoxazine substituted phenol monomer, preparation method, cured product and application 西安交通大学 2023-03-28 CN disclosed
CN-108884044-B Piperidine derivatives 大塚制药株式会社 2023-01-31 CN disclosed
WO-2014154762-A1 DIHYDROQUINAZOLINONE ANALOGUES AS BRD4 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-10-02 WO disclosed
US-20140296230-A1 DIHYDROQUINAZOLINONE ANALOGUES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-10-02 US disclosed
WO-2014154762-A1 DIHYDROQUINAZOLINONE ANALOGUES AS BRD4 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-10-02 WO disclosed
US-20140296230-A1 DIHYDROQUINAZOLINONE ANALOGUES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-10-02 US disclosed
US-20140296230-A1 DIHYDROQUINAZOLINONE ANALOGUES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-10-02 US disclosed
EP-2592083-A1 FUSED QUINAZOLINE DERIVATIVES AND USES THEREOF Shenzhen Salubris Pharmaceuticals Co., Ltd. (CN) 2013-05-15 EP disclosed
US-20110288086-A1 POLYCYCLIC QUINAZOLINES, PREPARATION THEREOF, AND USE THEREOF SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. (CN) 2011-11-24 US disclosed
WO-2001044184-A1 SYNTHESIS OF INDOLE-CONTAINING SPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 2001-06-21 WO disclosed
EP-0773944-A1 BENZYL-IMIDAZOPYRIDINES Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1997-05-21 EP disclosed
WO-1996003403-A1 BENZYL-IMIDAZOPYRIDINES BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1996-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296230-A1 DIHYDROQUINAZOLINONE ANALOGUES MKI67, NQO2, CCNI ALDH1A1 87/4885ADRA2B 350/4885PTGS1 344/4885
US-20110288086-A1 POLYCYCLIC QUINAZOLINES, PREPARATION THEREOF, AND USE THEREOF AURKA, AURKC, AURKB ALDH1A1 3950/4885ADRA2B 4107/4885PTGS1 4163/4885
US-20250179052-A1 PYRIMIDINYL-OXY-QUINOLINE BASED HERBICIDAL COMPOUNDS PRXL2A, QDPR, PRDX1 ALDH1A1 351/4885ADRA2B 1309/4885PTGS1 1234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.